NCBiotech News

North Carolina’s economic development efforts are recognized in Business Facilities magazine’s 2020 Metro Rankings Report, with the City of Raleigh number one on its list of GDP leaders in mid-size metro markets.

The North Carolina Biotechnology Center awarded 34 grants and loans totaling nearly $2 million to universities, biosciences companies and other entities in the fourth quarter of its last fiscal year.

Grifols, a global biotherapeutics company with major operations in North Carolina, has delivered the first batches of a therapeutic product manufactured in Clayton that could help prevent and treat COVID-19 infection.

North Carolina’s strength in the life sciences and its strong business climate have landed it, again, among the nation’s best on Business Facilities Magazine's 16th Annual Rankings Report for 2020.

Greensboro diagnostics and drug screening company Carolina Liquid Chemistries (CLC) is now selling COVID-19 test kits.

The NCBiotech-supported Summer Undergraduate Research Program at Western Carolina University has adapted well to the world of digital communication.

Raleigh pharmaceutical upstart 9 Meters Biopharma has secured patent protection for its potential gastrointestinal drug for additional use in treating lung disease. 

RTP oncology company G1 Therapeutics has out-licensed a potential drug for treating certain breast and lung cancers to a Massachusetts startup in a deal that could be worth more than $300 million.

RTP-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic researchers as part of its efforts to accelerate research on how COVID-19 is impacting the healthcare industry and related treatment.

Winston-Salem's EncepHeal Therapeutics has landed a federal grant to support development of its novel medications for cocaine addiction.

Less than two years after launching, Avior Bio is kicking off its first human trial for a novel drug therapy treating pruritus, or chronic itchy skin

RTP-based Panaceutics Nutrition has launched I-Vive, a new line of single-serve nutritional products compounded for the general public

North Carolina’s global leadership in biomanufacturing has drawn another spotlight with a White House announcement that President Donald Trump will be visiting the Triangle on Monday, July 27, to a company involved in producing COVID-19 vaccine.

Boragen, Inc., a boron-based discovery platform company based in RTP, has won a $300,500 Phase I Small Business Innovation Research grant for research on controlling malaria.

Chapel Hill's Path BioAnalytics has joined forces with Australian researchers to study a new drug to fight COVID-19